Rocket Lab USA, Inc. Announces Director Changes
Ticker: RKLB · Form: 8-K · Filed: Apr 18, 2024 · CIK: 1819994
| Field | Detail |
|---|---|
| Company | Rocket Lab USA, Inc. (RKLB) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation
Related Tickers: RKLB
TL;DR
Rocket Lab swapped a director and is adjusting executive pay. Board changes incoming.
AI Summary
Rocket Lab USA, Inc. announced on April 12, 2024, the departure of director Dr. Peter Beck and the appointment of Dr. Adam Keal as a new director. The company also disclosed compensatory arrangements for certain officers, though specific details and dollar amounts were not provided in this initial filing.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future decision-making.
Risk Assessment
Risk Level: low — The filing primarily concerns routine board and executive compensation updates, with no immediate financial or operational risks indicated.
Key Players & Entities
- Rocket Lab USA, Inc. (company) — Registrant
- Dr. Peter Beck (person) — Departing Director
- Dr. Adam Keal (person) — Appointed Director
- April 12, 2024 (date) — Date of earliest event reported
FAQ
Who has departed from Rocket Lab's board of directors?
Dr. Peter Beck has departed from Rocket Lab's board of directors as of April 12, 2024.
Who has been appointed as a new director to Rocket Lab's board?
Dr. Adam Keal has been appointed as a new director to Rocket Lab's board.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 12, 2024.
What other item is covered in this 8-K filing besides director changes?
This 8-K filing also covers compensatory arrangements of certain officers.
What is Rocket Lab USA, Inc.'s state of incorporation?
Rocket Lab USA, Inc. is incorporated in Delaware.
Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-04-18 16:15:27
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share RKLB The Nasdaq Stock Mar
Filing Documents
- rklb-20240412.htm (8-K) — 39KB
- rklb-ex99_1.htm (EX-99.1) — 13KB
- img121456790_0.jpg (GRAPHIC) — 214KB
- 0000950170-24-045569.txt ( ) — 462KB
- rklb-20240412.xsd (EX-101.SCH) — 24KB
- rklb-20240412_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release of Rocket Lab USA, Inc., dated April 18, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKET LAB USA, INC. Date: April 18, 2024 By: /s/ Arjun Kampani Arjun Kampani Senior Vice President, General Counsel, and Corporate Secretary